MedPath

The Effects of preoperative continue Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on postoperative Acute Kidney Injury after Coronary Artery Bypass Graft Surgery

Registration Number
TCTR20210824011
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
250
Inclusion Criteria

1. Coronary artery bypass graft surgery with cardiopulmonary bypass.
2. Aged at least 18 years.

Exclusion Criteria

1. Involve aortic surgery.
2. Emergency surgery.
3. Prior sternotomy.
4. Prior expose contrast agent within 72 hr preoperative
5. Off-pump CABG converted to on-pump CABG
6. Preoperative serum creatinine more than or equal to 2 mg/dL., need preoperative dialysis or prior kidney transplant.
7. Preoperative ECMO or Need post-op ECMO in 7 days after surgery
8. Died within 7 days postoperative
9. Incomplete data collection

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of continue ACEI/ARB and AKI as KDIGO staging after CABG surgery with CPB at ICU admission (T1), postoperative day 1, 2, and 5-7 (T2, T3, T4). Retrospective chart review between January 1, 2018, to May 31, 2021. Regression analysis
Secondary Outcome Measures
NameTimeMethod
1.Postoperative vasoactive inotropic score (VIS) at ICU admission (T1), postoperative day 1, and day 2 (T2, T3). Retrospective chart review between January 1, 2018, to May 31, 2021 Regression analysis,2.Postoperative vasodilator within 24 h Retrospective chart review between January 1, 2018, to May 31, 2021 Regression analysis,3. In hospital morbidity Retrospective chart review between January 1, 2018, to May 31, 2021 Regression analysis,4.Hospital length of stay and condition of discharge Retrospective chart review between January 1, 2018, to May 31, 2021 Regression analysis,5. In hospital mortality Retrospective chart review between January 1, 2018, to May 31, 2021 Regression analysis,6. 30-day readmission and mortality Retrospective chart review between January 1, 2018, to May 31, 2021 Regression analysis
© Copyright 2025. All Rights Reserved by MedPath